Janumet and Breastfeeding
Certain people should use caution when taking a diabetes medication like Janumet. Breastfeeding women should talk to their healthcare provider about taking the drug while nursing because it has been shown to pass through breast milk in animals. Talking to your healthcare provider about Janumet and breastfeeding can help minimize risks and ensure a safe treatment process.
It is not known if Janumet® (sitagliptin and metformin) is passed through breast milk. However, because of the potentially serious side effects that could occur in the nursing infant, the manufacturer of Janumet recommends that the drug be used with caution in breastfeeding women. If you are breastfeeding or thinking of breastfeeding, make sure to let your healthcare provider know.
Metformin (one of the ingredients in Janumet) is passed through breast milk in low amounts. No research has been done to see if sitagliptin (another ingredient) is passed through breast milk in humans. However, both are passed through breast milk in rats. If your healthcare provider recommends Janumet while breastfeeding, be sure to watch for any side effects in your child.
You should talk with your healthcare provider about Janumet and breastfeeding. Everyone's situation is different, and your healthcare provider understands your situation best. After considering what you want and expect (and your current health situation), you and your healthcare provider can make a shared decision about Janumet and breastfeeding that is right for you.